On February 2, 2026, U.S. District Court for the Eastern District of Pennsylvania Judge Joshua D. Wolson, sitting by ...

Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and ...

Vaccination is one of the greatest achievements in immunology and medicine, nearly eradicating many infectious diseases that ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

RNA-3927 is a strong strategic fit with Recordati’s rare Metabolic portfolioCollaboration combines Moderna’s expertise in mRNA technology for ...

The biotech’s licensing pact with Pfizer, revealed last week, will leverage its adjuvant vaccine platform in the development ...

Scientists have made the first step towards creating new species in the lab. Researchers have used artificial intelligence to ...

The MarketBeat analysts will have every angle covered. Here are some of our most popular articles from this week. Articles by Thomas Hughes Chip stocks have been recovering from a year-end sell-off.

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...

A new study in Nature Communications reveals how immune cells rapidly shut down their response after activation, preventing damage to healthy tissue ...

“It’s been known for a long time that obesity causes uncontrolled inflammation, but no one knew the mechanism behind it. ‌Our ...

Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...